Global Virtual Biopsy Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Virtual Biopsy market size will reach US$ 1648 million by 2031.
virtual biopsy is a non - invasive or minimally invasive medical diagnostic technique that uses advanced imaging technologies and computer - based analysis to obtain detailed information about the structure, function, and pathological characteristics of tissues or organs within the body, mimicking the role of a traditional tissue biopsy.
In a virtual biopsy, instead of physically removing a tissue sample through a surgical or invasive procedure, high - resolution imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, or optical coherence tomography (OCT) are employed to capture detailed images of the target area. These images are then processed and analyzed using sophisticated software algorithms to extract quantitative and qualitative data about the tissue, including its cellular and molecular features, metabolic activity, and vascular patterns. This approach allows clinicians to make a more accurate diagnosis, assess the progression of diseases, and monitor the response to treatment without the risks and complications associated with traditional biopsies.
United States market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Virtual Biopsy players cover GE Healthcare, Siemens Healthineers, BRAINSPEC, Oncoustics, Imaging Biometrics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Virtual Biopsy Industry Forecast” looks at past sales and reviews total world Virtual Biopsy sales in 2024, providing a comprehensive analysis by region and market sector of projected Virtual Biopsy sales for 2025 through 2031. With Virtual Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Virtual Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virtual Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Magnetic Resonance Imaging
Computed Tomography
X-ray
Ultrasound
Others
Segmentation by Application:
Hospitals and Clinics
Diagnostic Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Siemens Healthineers
BRAINSPEC
Oncoustics
Imaging Biometrics
OptoVibronex
ImageBiopsy Lab
Median Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
virtual biopsy is a non - invasive or minimally invasive medical diagnostic technique that uses advanced imaging technologies and computer - based analysis to obtain detailed information about the structure, function, and pathological characteristics of tissues or organs within the body, mimicking the role of a traditional tissue biopsy.
In a virtual biopsy, instead of physically removing a tissue sample through a surgical or invasive procedure, high - resolution imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, or optical coherence tomography (OCT) are employed to capture detailed images of the target area. These images are then processed and analyzed using sophisticated software algorithms to extract quantitative and qualitative data about the tissue, including its cellular and molecular features, metabolic activity, and vascular patterns. This approach allows clinicians to make a more accurate diagnosis, assess the progression of diseases, and monitor the response to treatment without the risks and complications associated with traditional biopsies.
United States market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Virtual Biopsy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Virtual Biopsy players cover GE Healthcare, Siemens Healthineers, BRAINSPEC, Oncoustics, Imaging Biometrics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Virtual Biopsy Industry Forecast” looks at past sales and reviews total world Virtual Biopsy sales in 2024, providing a comprehensive analysis by region and market sector of projected Virtual Biopsy sales for 2025 through 2031. With Virtual Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Virtual Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virtual Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Magnetic Resonance Imaging
Computed Tomography
X-ray
Ultrasound
Others
Segmentation by Application:
Hospitals and Clinics
Diagnostic Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Siemens Healthineers
BRAINSPEC
Oncoustics
Imaging Biometrics
OptoVibronex
ImageBiopsy Lab
Median Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Virtual Biopsy Market Size by Player
- 4 Virtual Biopsy by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Virtual Biopsy Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
